and, on top of this, the company developed a trial for this "de-risked" product with "proven potency and efficacy" that was specifically designed to screen out patients who were not likely to respond well...and all the time they hid from us the debacle about the fraudulent withdrawn QUT research papers....
Ann: Shareholder Update, page-8
Add DLM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.227M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| DLM (ASX) Chart |
Day chart unavailable